Heron Therapeutics, Inc. earnings per share and revenue

HRTX earnings per share for the last quarter are -0.06 USD whereas the estimation was -0.04 USD which accounts for -52.67% surprise. Company revenue for the same period amounts to 36.00 M USD despite the estimated figure of 36.09 M USD. Estimated earnings per share for the next quarter are -0.04 USD, and revenue is expected to reach 36.77 M USD. Also watch annual changes over time to get a bigger picture of HRTX earnings per share and revenue dynamics.